Sandrine Prost graduated from the University Pierre and Marie Curie, (Paris VI, France) with a PhD in molecular pharmacology studying mechanisms of resistance to antitumor agents that target topoisomerases. She then joined the University of Edinburgh as a European Commission Marie Curie Research Fellow to work on the role of P53 in apoptosis and DNA repair. Her interests developed from carcinogenesis and the role of tumour suppressor genes in cell responses to injury, in particular the effects of DNA damage & the cell cycle responses to a wider theme of cell injury. She became senior lecturer in 2001 in the Liver Injury & Repair Group of the university department of Pathology.

 I am interested in the cellular reactions to injury and their role in determining pathogenesis and disease outcome. Our current translational research aims to identify within the diseased tissue new biomarker combinations to improve the recognition and management of inflammatory renal and hepatic disease. We have been using RNAscope (ACDbio) to sensitively detect low level hepatitis viral RNA in situ within tissue samples and multispectral imaging (Nuance Perkin Elmer) in the per-cell evaluation of multiple (5+) markers on clinical biopsy samples. Recent work includes a detailed comparative in situ phenotyping study of macrophages in clinical inflammatory and allo-immune conditions affecting the liver and kidney.